1. Home
  2. CADL vs BHB Comparison

CADL vs BHB Comparison

Compare CADL & BHB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$8.56

Market Cap

578.8M

Sector

Health Care

ML Signal

HOLD

Logo Bar Harbor Bankshares Inc.

BHB

Bar Harbor Bankshares Inc.

HOLD

Current Price

$36.97

Market Cap

583.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
BHB
Founded
1999
1887
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
578.8M
583.8M
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
CADL
BHB
Price
$8.56
$36.97
Analyst Decision
Strong Buy
Buy
Analyst Count
7
3
Target Price
$19.00
$37.00
AVG Volume (30 Days)
2.0M
76.5K
Earning Date
05-14-2026
04-21-2026
Dividend Yield
N/A
3.95%
EPS Growth
58.62
N/A
EPS
N/A
0.81
Revenue
$125,000.00
N/A
Revenue This Year
N/A
$22.68
Revenue Next Year
N/A
$3.66
P/E Ratio
N/A
$45.20
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$28.06
52 Week High
$9.57
$37.20

Technical Indicators

Market Signals
Indicator
CADL
BHB
Relative Strength Index (RSI) 56.76 68.99
Support Level $4.80 $33.85
Resistance Level $9.42 N/A
Average True Range (ATR) 0.57 0.87
MACD -0.09 0.20
Stochastic Oscillator 37.35 92.60

Price Performance

Historical Comparison
CADL
BHB

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About BHB Bar Harbor Bankshares Inc.

Bar Harbor Bankshares Inc is a bank holding company along with its subsidiaries that offers a full range of financial services products, brokerage services through third-party brokerage arrangements, and also trust and investment management services to individuals, businesses, non-profit organizations, and municipalities. Its products and services consist of checking, deposits, cards, mobile banking, online services, loans, merchant services, trust, fiduciary services, investment planning, education funding, and individual retirement planning.

Share on Social Networks: